Announcement
05 Aug 2020
On 5 August 2020, BARDA provided USD 1 billion to Janssen Pharmaceutical for the production of investigational COVID-19 vaccine doses.
Source
Sign in to access
Number of interventions
2
1 certainly harmful
1 likely harmful
0 liberalising
List of interventions
Implementation date
05 Aug 2020
Revocation date:
No revocation date
Updated: 05 Aug 2020
Export-related non-tariff measure, nes
In force
On 5 August 2020, the Biomedical Advanced Research and Development Authority (BARDA) announced awarding USD 1 billion to Janssen Pharmaceutical Companies of Johnson and Johnson for the production o...
Sign in to see more
Implementation date
05 Aug 2020
Revocation date:
No revocation date
Updated: 05 Aug 2020
State aid, unspecified
In force
On 5 August 2020, the U.S. Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) in coordination with the Department of Defense announced awa...
Sign in to see more
Related State Acts
25 Mar 2021
United States of America: BARDA provides funding to Janssen Pharmaceuticals to support their COVID-19 vaccine Phase 2a clinical trials trial to include adolescents
13 Nov 2020
United States of America: BARDA provides $454.3 million funding to Janssen Pharmaceuticals to support their COVID-19 vaccine Phase 3 clinical trials in adults
21 Aug 2020
United States of America: BARDA provides $85.3 million funding to Janssen Pharmaceuticals to support Janssen’s COVID-19 vaccine phase 2 clinical trials and additional non-clinical studies
27 Mar 2020
United States of America: BARDA provides $435 million funding to Janssen Pharmaceuticals to support Janssen’s vaccine candidate through phase 3 clinical trials
11 Feb 2020
United States of America: BARDA collaborates with Janssen Pharmaceuticals to accelerate clinical trials and manufacturing of COVID-19 vaccine
Threads
See all
This state act is not part of any Thread yet.